Severe sleep apnea/hypopnea syndrome Nervous System Diseases Sleep apnoea
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age between 18-75 years 2. Recently diagnosed with severe sleep apnea and do not have any previous experience or information with this pathology 3. Consent signed
Exclusion criteria
Exclusion criteria: 1. IMC (BMI) >40 kg/m² 2. Inability to fill up questionnaires 3. Severe drug or alcohol abuse 4. Hypnotic medication 5. Not controlled coronary disease 6. Decompensated Heart failure 7. Stroke 8. Systemic Disease associated with inflammatory diagnosed entity (arthritis, sarcoidosis, vasculitis, lupus…) 9. Neuromuscular disease (like Duchenne) 10. Craniofacial deformities. 11. Active oncologic process. 12. Any antecedents of MT treatment or other treatment for sleep apnea could affect study results of the study (surgery, DAM or CPAP). Once the patient accepted and signed consent and met inclusion criteria, they will be attended by Ent specialist to rule out: 13. Severe upper airway obstruction (Complete nose obstruction, Tonsills grade IV/IV ) 14. Presence of tongue tie (Marchesani Protocole) with limitation of tongue movements 15. Antecedents or presence of temporomandibular joint disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| At baseline and 3 months: 1. Severity of apnea measured using The Apnea–Hypopnea Index 2. Saturation O2 and Nadir O2 measured using oximeter 3. Tongue strength measured using the Iowa Oral Performance Instrument (IOPI) | — |
Secondary
| Measure | Time frame |
|---|---|
| Measured each month for 3 months: 1. Sleep quality measured using Pittsburgh Sleep Quality Index (PSQI) 2. Sleepiness measured using Epworth sleepiness scale 3. BMI (kg/m²) 4. Neck and waist circumference (cm) | — |
Countries
Spain